Hoisnard L, Pina Vegas L, Dray-Spira R, Weill A, et al. Risk of major adverse cardiovascular and venous thromboembolism events in patients with rheumatoid arthritis exposed to JAK inhibitors versus adalimumab: a nationwide cohort study. Ann Rheum Dis 2022 Oct 5. pii: ard-2022-222824. doi: 10.1136/ard-2022-222824.
PMID: 36198438